TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19614974

Group type: EXPERIMENTAL
Intervention: Behavioural two‐alternative forced‐choice tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pitch variation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnetoencephalography (MEG) analysis of N100m
Number of subjects: 0
Study: 17267530

Group type: EXPERIMENTAL
Intervention: Computer tutorials (6 tutorials installed on a computer in the emergency department, each lasting 10 minutes)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Computer tutorials
Number of subjects: 95
Study: 15482765

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Combination of metformin and rosiglitazone
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 11737418

Group type: EXPERIMENTAL
Intervention: Transdermal DHT and one subdermal LNG implant
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Transdermal DHT and two subdermal LNG implants
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Transdermal DHT and four subdermal LNG implants
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Transdermal DHT and oral LNG
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Transdermal DHT only
Number of subjects: 43
Study: 9050428

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral treatment of anxiety
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (within-subjects controlled trial)
Number of subjects: 0
Study: 7937352

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) infusion (4 pmol.kg‐1.min‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Physiological saline infusion
Number of subjects: 10
Study: 31969108

Group type: EXPERIMENTAL
Intervention: Remote model intervention with at-home, parent-delivered intervention and weekly video conferencing with interventionists.
Number of subjects: 30
Study: 29878280

Group type: EXPERIMENTAL
Intervention: 200 mg of L-DOPA
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 28973211

Group type: EXPERIMENTAL
Intervention: IVIg (0.5 g/kg of body weight)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo (0.1% albumin in saline)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: IVIg (2 infusions) in open extension
Number of subjects: 111
Study: 25647278

Group type: EXPERIMENTAL
Intervention: Reconstructive surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Facial defects
Number of subjects: 120
Study: 22921176

Group type: EXPERIMENTAL
Intervention: Dignity Therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group participation
Number of subjects: 29
Study: 21403043

Group type: EXPERIMENTAL
Intervention: Guided care
Number of subjects: 850

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 850
Study: 18313032

Group type: EXPERIMENTAL
Intervention: Incremental theory manipulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 16441945

Group type: EXPERIMENTAL
Intervention: 600 g fruit and vegetables/day
Number of subjects: 43

Group type: COMPARATOR
Intervention: Carbohydrate-rich drink (control)
Number of subjects: 43
Study: 12829681

Group type: EXPERIMENTAL
Intervention: Primary systemic therapy (PST)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recommendations regarding PST regimens and techniques
Number of subjects: 0
Study: 10623700

Group type: EXPERIMENTAL
Intervention: Cisplatin (100 mg/m(2))
Number of subjects: 614

Group type: COMPARATOR
Intervention: Paclitaxel (200 mg/m(2) 24-hour infusion)
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Combination of paclitaxel (135 mg/m(2)) followed by cisplatin (75 mg/m(2))
Number of subjects: 614
Study: 9098913

Group type: EXPERIMENTAL
Intervention: Stress reduction program conducted by worksite supervisors over 1 year
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Stress reduction program
Number of subjects: 5
Study: 1489290

Group type: COMPARATOR
Intervention: Aspirin 100 mg
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg + Dipyridamole 300 mg
Number of subjects: 101
Study: 2418296

Group type: EXPERIMENTAL
Intervention: Nicorandil (60 mg s.l.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN; 20 mg s.l.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dihydralazine (10 mg i.v.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31455312

Group type: EXPERIMENTAL
Intervention: Hand therapy (includes oedema and scar management, splinting, movement exercises, and practice of everyday activities)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Hand therapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 160
Study: 29065098

Group type: EXPERIMENTAL
Intervention: Sodium nitrite (NaNO2) infusion at 240 μg/kg/h for 2 hours
Number of subjects: 28

Group type: COMPARATOR
Intervention: Isotonic saline infusion
Number of subjects: 28
Study: 27880811

Group type: EXPERIMENTAL
Intervention: Ondansetron (0.15 mg/kg)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Domperidone (0.5 mg/kg)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study: 25092547

Group type: EXPERIMENTAL
Intervention: 8 mg/day dexamethasone for 28 days followed by a 2-week taper (enhanced)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 6 mg/day dexamethasone for 10 days (conventional)
Number of subjects: 32
Study: 23232787

Group type: EXPERIMENTAL
Intervention: Plavix
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generic clopidogrel hydrochloride
Number of subjects: 0
Study: 20225326

Group type: EXPERIMENTAL
Intervention: Single fraction radiotherapy (1 x 8 Gy)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Multiple fraction radiotherapy (6 x 4 Gy)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 274
Study: 17660129

Group type: EXPERIMENTAL
Intervention: Small access appendectomy (SAA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional appendectomy (CAP)
Number of subjects: 120
Study: 16222011

Group type: EXPERIMENTAL
Intervention: Maternal parasitemia at the first antenatal visit
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Maternal parasitemia at delivery
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Cord parasitemia
Number of subjects: 275
Study: 11856793

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (target temperature, 32 degrees C to 34 degrees C, for 24 hours)
Number of subjects: 273

Group type: COMPARATOR
Intervention: Normothermia (standard treatment)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 273

Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 273
Study: 10912975

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 7710563

Group type: EXPERIMENTAL
Intervention: Diltiazem (180 to 360 mg/day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 2278366

Group type: EXPERIMENTAL
Intervention: APA (acute parenteral alimentation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (0.9% NaCl solution)
Number of subjects: 20
Study: 364003

Group type: EXPERIMENTAL
Intervention: 1% Chlorhexidine gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31938878

Group type: EXPERIMENTAL
Intervention: Ayahuasca ceremonies
Number of subjects: 50
Study: 31066115

Group type: EXPERIMENTAL
Intervention: Self-efficacy-focused structured education programme
Number of subjects: 265

Group type: COMPARATOR
Intervention: Routine education (Control)
Number of subjects: 265
Study: 25438821

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Dapagliflozin
Number of subjects: 2
Study: 23615407

Group type: EXPERIMENTAL
Intervention: iMR imaging group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 21323176

Group type: EXPERIMENTAL
Intervention: DTPa-IPV/Hib vaccine
Number of subjects: 3292

Group type: EXPERIMENTAL
Intervention: DTPa-HBV-IPV/Hib vaccine
Number of subjects: 3292

Group type: EXPERIMENTAL
Intervention: Booster dose of DTPa-IPV/Hib
Number of subjects: 3292

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 3292
Study: 19586144

Group type: EXPERIMENTAL
Intervention: Body image challenge (trying on a bathing suit)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control condition (evaluating a purse)
Number of subjects: 133
Study: 17448442

Group type: EXPERIMENTAL
Intervention: Implicit cognitive associations with smoking
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Density of smokers in participants' social environment
Number of subjects: 67
Study: 14531817

Group type: EXPERIMENTAL
Intervention: Very low protein diet (VLPD) group (0.3 g/kg body weight/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low protein diet (LPD) group (0.6 g/kg body weight/day)
Number of subjects: 20
Study: 11036964

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 87

Group type: COMPARATOR
Intervention: Megestrol Acetate (MA)
Number of subjects: 87
Study: 9390977

Group type: EXPERIMENTAL
Intervention: Microgravity (microG)
Number of subjects: 4

Group type: COMPARATOR
Intervention: 1 G
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Approximately 1.6 G
Number of subjects: 4

Group type: COMPARATOR
Intervention: 1 G and approximately 1.6 G
Number of subjects: 4
Study: 8150902

Group type: EXPERIMENTAL
Intervention: Subcutaneous goserelin (3.6 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intranasal buserelin acetate (200 micrograms; 6 times/day)
Number of subjects: 100
Study: 3784304

Group type: EXPERIMENTAL
Intervention: Nondialyzed patients with chronic renal failure
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Patients undergoing maintenance hemodialysis
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal individuals
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups (normal, nondialyzed, hemodialysis)
Number of subjects: 36
Study: 30294848

Group type: EXPERIMENTAL
Intervention: Gastrografin (100 mL administered through nasointestinal tube once daily for six consecutive days)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Enemas (administered once daily for six consecutive days)
Number of subjects: 83
Study: 30278566

Group type: EXPERIMENTAL
Intervention: Montmorillonite powder
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 58
Study: 26498504

Group type: EXPERIMENTAL
Intervention: Disease Control Rate (DCR) at 8 weeks
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Elevated lactate dehydrogenase
Number of subjects: 263
Study: 24660675

Group type: EXPERIMENTAL
Intervention: Weekly dynamic psychotherapy with relationship work
Number of subjects: 100

Group type: COMPARATOR
Intervention: Weekly dynamic psychotherapy without relationship work
Number of subjects: 100
Study: 22113935

Group type: EXPERIMENTAL
Intervention: Screening tool for osteoporotic vertebral fractures (VFs) administered by a nurse in primary care.
Number of subjects: 3200

Group type: COMPARATOR
Intervention: Control group (no screening tool or radiographs).
Number of subjects: 3200
Study: 19107626

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) supplementation (8 g/day)
Number of subjects: 45
Study: 17443036

Group type: EXPERIMENTAL
Intervention: NSAID-ET (NSAID plus etizolam 0.5 mg)
Number of subjects: 144

Group type: COMPARATOR
Intervention: NSAID (mefenamic acid 250 mg)
Number of subjects: 144
Study: 16046372

Group type: EXPERIMENTAL
Intervention: CCK‐4 injection
Number of subjects: 28
Study: 12032191

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg o.d.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 10188113

Group type: EXPERIMENTAL
Intervention: Oral lorazepam 0.025 mg/kg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 8540943

Group type: EXPERIMENTAL
Intervention: 5% dextrose infusion at 180 mL/h (9 g/h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% saline solution
Number of subjects: 0
Study: 2089144

Group type: EXPERIMENTAL
Intervention: Clonidine and cyproheptadine with interactive locomotor training
Number of subjects: 2
Study: 516362

Group type: EXPERIMENTAL
Intervention: delta 9-tetrahydrocannabinol (THC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 31710398

Group type: EXPERIMENTAL
Intervention: Topical alprostadil
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intracavernous injection
Number of subjects: 80
Study: 30206130

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC) at 2 L/kg/min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC) at 1 L/kg/min
Number of subjects: 10

Group type: COMPARATOR
Intervention: Face mask delivery
Number of subjects: 10
Study: 27723577

Group type: EXPERIMENTAL
Intervention: DASC (Dense Adaptive Self-Correlation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GI-DASC (Geometry-Invariant DASC)
Number of subjects: 0
Study: 25779892

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) for 12 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 31
Study: 23980043

Group type: EXPERIMENTAL
Intervention: Early oral feeding with enteral nutrition
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional postoperative care protocol
Number of subjects: 48
Study: 21366964

Group type: EXPERIMENTAL
Intervention: MSM+EDTA lotion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MSM alone
Number of subjects: 0
Study: 19644033

Group type: EXPERIMENTAL
Intervention: Maximal voluntary isometric contractions (MVICs)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Static plantar flexor stretches
Number of subjects: 16
Study: 17684963

Group type: EXPERIMENTAL
Intervention: Epoetin and iron preparations
Number of subjects: 189

Group type: COMPARATOR
Intervention: Untreated anemia (Control group)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Higher doses of epoetin and parenteral iron preparations
Number of subjects: 189
Study: 15173493

Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg/day
Number of subjects: 63

Group type: COMPARATOR
Intervention: Nedocromil 16 mg/day
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 11705138

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9646297

Group type: EXPERIMENTAL
Intervention: disease-specific (reduced-carbohydrate, modified-fat) formula
Number of subjects: 30

Group type: COMPARATOR
Intervention: standard high-carbohydrate formula
Number of subjects: 30
Study: 8572070

Group type: EXPERIMENTAL
Intervention: Ofloxacin eardrops
Number of subjects: 56

Group type: COMPARATOR
Intervention: Augmentin
Number of subjects: 56
Study: 6242073

Group type: EXPERIMENTAL
Intervention: Topically applied clindamycin phosphate 1% b.i.d.
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Oral tetracyclines 500 mg b.i.d.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 31524347

Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% lotion
Number of subjects: 69

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 69
Study: 29617739

Group type: EXPERIMENTAL
Intervention: RBX2660 (2 doses)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (2 doses)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: RBX2660 (1 dose) followed by Placebo (1 dose)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: RBX2660 (1 dose)
Number of subjects: 100
Study: 27046798

Group type: EXPERIMENTAL
Intervention: High dose antithrombin (3000 IU/daily)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (1% glycine)
Number of subjects: 38
Study: 24520915

Group type: EXPERIMENTAL
Intervention: General practitioners (GPs) faxed invitations with telephone follow-up
Number of subjects: 3893

Group type: EXPERIMENTAL
Intervention: Older people invited through reply-paid cards with telephone follow-up
Number of subjects: 3893

Group type: EXPERIMENTAL
Intervention: GP's length of time at the practice and training in New Zealand
Number of subjects: 3893
Study: 22185431

Group type: EXPERIMENTAL
Intervention: 1.62% testosterone gel (81 mg testosterone) applied once daily for 7 days with washing at 2 hours post-dose
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1.62% testosterone gel (81 mg testosterone) applied once daily for 7 days with washing at 6 hours post-dose
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1.62% testosterone gel (81 mg testosterone) applied once daily for 7 days with washing at 10 hours post-dose
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1.62% testosterone gel (81 mg testosterone) applied once daily for 7 days with no washing
Number of subjects: 24
Study: 20559225

Group type: EXPERIMENTAL
Intervention: Cycloferon
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional drug therapy
Number of subjects: 61
Study: 17912169

Group type: EXPERIMENTAL
Intervention: Bone marrow stem cell therapy (BM-derived cells injected into infarcted hearts)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group in initial randomized trials)
Number of subjects: 0
Study: 17299062

Group type: EXPERIMENTAL
Intervention: Dutasteride (0.5 mg)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 14760334

Group type: EXPERIMENTAL
Intervention: 12-week progressive home walking exercise program (n = 42)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Usual activity control group (n = 37)
Number of subjects: 79
Study: 10798473

Group type: EXPERIMENTAL
Intervention: Abilities-focused program of morning care
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 84
Study: 8780347

Group type: EXPERIMENTAL
Intervention: 50 mg gastric-delivery-system (GDS) iron supplement
Number of subjects: 0

Group type: COMPARATOR
Intervention: 120 mg conventional (Con) iron supplement
Number of subjects: 0
Study: 1622308

Group type: EXPERIMENTAL
Intervention: Social support intervention
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 88
Study: 6503365

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 70
Study: 30719455

Group type: EXPERIMENTAL
Intervention: Chronic Care Model-based intervention
Number of subjects: 300
Study: 28856398

Group type: EXPERIMENTAL
Intervention: Current use of SSRIs (last tablet noted ≤ 7 days before diagnosis)
Number of subjects: 9262

Group type: EXPERIMENTAL
Intervention: Late use of SSRIs (last tablet noted ≥ 8 days before diagnosis)
Number of subjects: 9262

Group type: COMPARATOR
Intervention: No use of SSRIs (never prescribed SSRIs)
Number of subjects: 9262
Study: 26195460

Group type: EXPERIMENTAL
Intervention: Long-lasting permethrin-impregnated clothing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects (not wearing treated uniforms)
Number of subjects: 0
Study: 23916987

Group type: EXPERIMENTAL
Intervention: S. Typhi ISP1820
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: S. Typhi Ty2 RpoS(-)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: S. Typhi Ty2 RpoS(+)
Number of subjects: 60
Study: 21175345

Group type: EXPERIMENTAL
Intervention: Irradiated eyes of 1-year-old rats exposed to 2 Gy of (56)Fe ions
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Older ovariectomized rats receiving exogenous estrogen treatment (17-β-estradiol)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Irradiated eyes of young rats
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Modulation of estrogen status in 1-year-old animals (e.g., ovariectomy or continuous exposure to estrogen)
Number of subjects: 2
Study: 18501444

Group type: EXPERIMENTAL
Intervention: Continuous Exercise (CE)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Interval Exercise (IE)
Number of subjects: 52
Study: 16704586

Group type: EXPERIMENTAL
Intervention: Single-breath vital capacity technique
Number of subjects: 73

Group type: COMPARATOR
Intervention: Tidal volume technique
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 73
Study: 15587771

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (AA) plus etomidate group
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (etomidate only)
Number of subjects: 22
Study: 11392363

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) at half dose
Number of subjects: 96
Study: 9427453

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (10^7 cfu)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (10^10 cfu)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 8276557

Group type: EXPERIMENTAL
Intervention: Enoxaparin (20 mg daily, starting 2 hours before surgery)
Number of subjects: 1122

Group type: COMPARATOR
Intervention: Calcium heparin (2 doses of 0.2 ml daily, starting 2 hours before surgery)
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 1122

Group type: COMPARATOR
Intervention: Calcium heparin
Number of subjects: 1122
Study: 3524744

Group type: EXPERIMENTAL
Intervention: Intramuscular chloroquine diphosphate, 2.5 mg base/kg at 0, 1, 12, 13, 24, and 25 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subcutaneous chloroquine diphosphate, 5 mg base/kg at 0, 12, and 24 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular chloroquine diphosphate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subcutaneous chloroquine diphosphate
Number of subjects: 0
Study: 28618198

Group type: EXPERIMENTAL
Intervention: IV paracetamol pre-emptive analgesia (15 mg/kg before treatment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: IV paracetamol preventive analgesia (15 mg/kg at the end of treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IV paracetamol pre-emptive analgesia
Number of subjects: 60